An epidemiological profile of chronic obstructive pulmonary disease: A community-based study in Delhi

被引:19
|
作者
Sinha, B. [1 ]
Vibha [1 ]
Singla, R. [2 ]
Chowdhury, R. [3 ]
机构
[1] Lady Hardinge Med Coll & Hosp, Dept Community Med, New Delhi, India
[2] Natl Inst TB & Resp Dis, Dept TB & Resp Dis, New Delhi, India
[3] RG Kar Med Coll, Dept Community Med, Kolkata, W Bengal, India
关键词
Chronic obstructive pulmonary disease; epidemiology; prevalence; risk factors; treatment seeking behavior; COPD; PREVALENCE; POPULATION; QUESTIONNAIRE; EXPOSURE; TRENDS;
D O I
10.4103/0022-3859.194200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Different definitions used for chronic obstructive pulmonary disease (COPD) preclude getting reliable prevalence estimates. Study objective was to find the prevalence of COPD as per standard Global Initiative for Chronic Obstructive Lung Disease definition, risk factors associated, and treatment seeking in adults >30 years. Methodology: Community-based cross-sectional study was conducted in Delhi, among 1200 adults, selected by systematic random sampling. Pretested questionnaire was used to interview all subjects and screen for symptoms of COPD. Postbronchodilator spirometry was done to confirm COPD. Statistical Analysis: Adjusted odds ratio (aOR) was calculated by multivariable analysis to examine the association of risk factors with COPD. Receiver operating characteristic (ROC) curve was developed to assess predictability. Results: The prevalence of COPD was 10.1% (95% confidence interval [CI] 8.5, 11.9%). Tobacco smoking was the strongest risk factor associated (aOR 9.48; 95% CI 4.22, 14.13) followed by environmental tobacco smoke (ETS), occupational exposure, age, and biomass fuel. Each pack-year of smoking increased 15% risk of COPD. Ex-smokers had 63% lesser risk compared to current smokers. Clinical allergy seems to preclude COPD (aOR 0.06; 95% CI 0.02, 0.37). ROC analysis showed 94.38% of the COPD variability can be assessed by this model (sensitivity 57.4%; positive predictive value 93.3%). Only 48% patients were on treatment. Treatment continuation was impeded by its cost. Conclusion: COPD prevalence in the region of Delhi, India, is high, and our case-finding population study identified a high rate of patients who were not on any treatment. Our study adds to creating awareness on the importance of smoking cessation, early diagnosis of COPD, and the need for regular treatment.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [31] Epidemiological study to investigate patients' views on chronic obstructive pulmonary disease (COPD)
    Georgatou, N.
    Papageorgiou, M.
    Pangali, M.
    Christodoulopoulou, A.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A266 - A266
  • [32] The effects of traffic-related air pollutants on chronic obstructive pulmonary disease in the community-based general population
    Hui-Tsung Hsu
    Chih-Da Wu
    Mu-Chi Chung
    Te-Chun Shen
    Ting-Ju Lai
    Chiu-Ying Chen
    Ruey-Yun Wang
    Chi-Jung Chung
    [J]. Respiratory Research, 22
  • [33] The effects of traffic-related air pollutants on chronic obstructive pulmonary disease in the community-based general population
    Hsu, Hui-Tsung
    Wu, Chih-Da
    Chung, Mu-Chi
    Shen, Te-Chun
    Lai, Ting-Ju
    Chen, Chiu-Ying
    Wang, Ruey-Yun
    Chung, Chi-Jung
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [34] Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort
    Allwood, B. W.
    Gillespie, R.
    Galperin-Aizenberg, M.
    Bateman, M.
    Olckers, H.
    Taborda-Barata, L.
    Calligaro, G. L.
    Said-Hartley, Q.
    van Zyl-Smit, R.
    Cooper, C. B.
    van Rikxoort, E.
    Goldin, J.
    Beyers, N.
    Bateman, E. D.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2017, 107 (05): : 440 - 445
  • [35] Investigation of drug interactions and patient profile with chronic obstructive pulmonary disease in a community pharmacy
    Yaban, Nurdan
    Tezcan, Songul
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1764 - 1765
  • [36] Impact of community-based chronic obstructive pulmonary disease service, a multidisciplinary intervention in an area of high deprivation: a longitudinal matched controlled study
    Saini, Pooja
    Rose, Tanith
    Downing, Jennifer
    Matata, Bashir
    Pilsworth, Samantha
    Pemberton, Allan
    Comerford, Terence
    Wilson, Keith
    Shaw, Matthew
    Harper, Lesley M.
    Daras, Konstantinos
    Barr, Benjamin
    [J]. BMJ OPEN, 2020, 10 (05):
  • [37] Safety profile of bupropion for chronic obstructive pulmonary disease
    García-Río, F
    Serrano, S
    Mediano, O
    Alonso, A
    Villamor, J
    [J]. LANCET, 2001, 358 (9286): : 1009 - 1009
  • [38] National epidemiological study of smoking cessation in danish patients with chronic obstructive pulmonary disease
    Andelius, Dea Kejlberg
    Hilberg, Ole
    Ibsen, Rikke
    Lokke, Anders
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [39] Cohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study
    Adab, P.
    Fitzmaurice, D. A.
    Dickens, A. P.
    Ayres, J. G.
    Buni, H.
    Cooper, B. G.
    Daley, A. J.
    Enocson, A.
    Greenfield, S.
    Jolly, K.
    Jowett, S.
    Kalirai, K.
    Marsh, J. L.
    Miller, M. R.
    Riley, R. D.
    Siebert, W. S.
    Stockley, R. A.
    Turner, A. M.
    Cheng, K. K.
    Jordan, R. E.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (01) : 23 - 23I
  • [40] The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry
    Kensuke Takabayashi
    Yuka Terasaki
    Miyuki Okuda
    Osamu Nakajima
    Hitoshi Koito
    Tetsuhisa Kitamura
    Shouji Kitaguchi
    Ryuji Nohara
    [J]. Heart and Vessels, 2021, 36 : 223 - 234